Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890)

Author: Dutcher Janice   Fine Jason   Krigel Robert   Murphy Barbara   Schaefer Paul   Ernstoff Marc   Loehrer Patrick  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.20, Iss.3, 2003-09, pp. : 271-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content